TEVA PHARMACEUTICAL-SP ADR (TEVA)

US8816242098 - ADR

13.81  +0.56 (+4.23%)

After market: 13.89 +0.08 (+0.58%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
15.85B14.93B15.88B16.66B16.89B
Minority Interest Expense
56.00M53.00M-39.00M109.00M2.00M
Cost Of Goods
7.87B7.49B8.01B8.87B9.35B
Gross Profit
7.98B7.44B7.86B7.79B7.54B
Operating Expenses
4.44B4.25B4.45B4.62B4.79B
Research and Development
953.00M838.00M967.00M997.00M1.01B
Selling, General, and Administrative Expenses
3.50B3.44B3.40B3.52B3.67B
Operating Income
3.54B3.19B3.42B3.17B2.75B
Interest Income/Expense
-991.00M-904.00M-988.00M-833.00M-825.00M
Other Income/Expense
-66.00M-62.00M-70.00M-1.00M3.00M
Non Recurring Items
-3.11B-5.38B-1.70B-6.74B-3.19B
Income Before Taxes
-624.00M-3.16B658.00M-4.41B-1.26B
Income Tax
-7.00M-643.00M211.00M-168.00M-278.00M
Net Income
-559.00M-2.45B417.00M-3.99B-999.00M
EBITDA
4.69B4.49B4.75B4.72B4.47B
 
Per Share Data
EPS Diluted Total Ops
-0.50-2.200.38-3.64-0.91
Non GAAP EPS
2.562.532.58N/AN/A
 
Statistics
Gross Profit Margin
50.33%49.84%49.53%46.76%44.63%
Profit Margin
-3.53%-16.39%2.63%-23.95%-5.92%
Operating Profit Margin
22.34%21.34%21.53%19.01%16.27%

All data in USD

Charts